CalciMedica (CALC) Earnings Analysis
CalciMedica (CALC) has no confirmed upcoming earnings date. Last quarter (2026-03-03) it beat with EPS -0.32 USD vs -0.55 USD est (+41.8%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -0.56.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CALC next report earnings?
No confirmed upcoming earnings date is currently scheduled for CALC. This page updates as the calendar is published.
CALC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-03 | -0.32 USD | -0.55 USD | +41.8% | Beat |
| 2025-11-12 | -0.39 USD | -0.41 USD | +4.9% | Beat |
| 2024-08-12 | -0.52 USD | -0.55 USD | +5.5% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
CALC valuation and analyst view
| Trailing P/E | -0.56 |
|---|---|
| Trailing EPS | -1.30195 USD |
| Price / book | -10.12 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (2 buy / 1 hold / 0 sell) |
Related research pages
Frequently asked questions
When is CalciMedica (CALC)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CALC. This page updates as the calendar is published.
Did CALC beat earnings last quarter?
In its 2026-03-03 report, CALC posted EPS of -0.32 USD versus a -0.55 USD estimate — a beat of 41.8%.
What is CALC's earnings track record?
Over the last 3 reported quarters with consensus data, CALC beat estimates 3 times (100%).
What is CALC's current P/E ratio and EPS?
CALC trades at a trailing P/E of -0.56 on trailing EPS of -1.301950707735848 USD.
What do analysts rate CALC?
Analyst consensus is "Buy" across 3 ratings (0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell).